Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111321193A reveals a novel enzymatic deracemization route for L-glufosinate. Discover cost-effective, high-yield manufacturing solutions for agrochemical intermediates.
Patent CN117568294A reveals P450 mutant for S-halohydrins. Offers green synthesis and supply chain stability for pharma intermediates.
CN117305198A reveals high-efficiency recombinant bacterium method for L-Dopa. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114908129B reveals a novel dehydrogenase mutant for high-purity (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering significant cost and supply chain advantages.
Patent CN110914417B reveals high-activity transaminase for chiral amine synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Discover the CN110699345A patent technology for enhanced stereoselectivity in chiral epoxide synthesis. Reliable supplier for pharmaceutical intermediates with cost-effective biocatalytic solutions.
Patent CN102382785A details a novel biocatalytic route for high-purity pregabalin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN115851694A details a novel immobilized enzyme method for synthesizing 2'-fluoro-deoxyribonucleosides, offering superior stability, reusability, and cost-effective manufacturing for antiviral intermediates.
Patent CN113652407B reveals a novel carbonyl reductase mutant enabling strict S-selectivity and enhanced activity for cost-effective chiral diol manufacturing.
Patent CN109897872B reveals enzymatic route for HIV intermediate. High conversion and purity ensure reliable pharmaceutical intermediates supplier capability for global procurement.
Patent CN109897872B details enzymatic reduction for HIV inhibitor intermediates. High purity and conversion enable cost reduction and reliable supply chain stability for global manufacturers.
Novel lipase mutant enables high-purity pregabalin intermediate production with improved activity and supply chain reliability for pharmaceutical manufacturing.
Novel transaminase mutants for chiral amine production. Enhanced stability at 55°C and pH 10. Cost-effective biocatalysis for pharma intermediates.
Patent CN101481665B reveals a green biocatalytic route for 2,2-dimethylcyclopropanecarboxamide, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102382780A reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain stability for global API manufacturers.
Patent CN108546698A reveals high-activity aspartase mutant for L-aspartic acid. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN120624390A enables high-purity chiral amine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110372641B reveals a novel enzymatic route for hexahydrofurofuranol derivatives, offering high optical purity and cost-effective manufacturing for API supply chains.
Patent CN101717810A enables efficient D-serine and L-tryptophan co-production. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN111944855B details a high-yield enzymatic route for (R)-1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethanol, offering superior stereoselectivity.